Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late Low-Dose Dexamethasone to Prevent BPD in Ventilated Preterm Neonates
NCT07904104Completed
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- Jun 2025
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexamethasone in bronchopulmonary dysplasia (BPD), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoints: Change in Fraction of Inspired Oxygen at 10 days, Change in Mean Airway Pressure at 10 days and 7 more. Started Jun 2025; status: completed.
02
Drugs
dexamethasone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT07904104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07904104.